发明名称 APOPTOSIS-BASED EVALUATION OF CHEMOSENSITIVITY IN CANCER PATIENTS
摘要 Induction of apoptosis in target cells is a key mechanism by which chemotherapy induces cell killing. An in vitro system has been established f or determining carboplatin and paclitaxel (Taxol) chemosensitivity of epithelia l ovarian cancer cells, where measurements of caspase-3 activation are surroga te markers for activation of chemotherapy-induced programmed cell death. To validate the assay as a predictor of clinical chemotherapy-induced programme d cell death. To validate the assay as a predictor of clinical chemosensitivit y in vitro apoptotic response were compared to the clinical response of the patients from whom the tumor cells were isolated. Caspase-3 activation in response to in vitro chemotherapy to both drugs was shown to have an 83 % positive predictive value and a 71 % negative predictive value. Markers of apoptosis such as caspase-3 activation can be quantitated and utilized to predict the clinical response to chemotherapy.
申请公布号 CA2547213(A1) 申请公布日期 2005.06.16
申请号 CA20042547213 申请日期 2004.11.26
申请人 YALE UNIVERSITY 发明人 MOR, GUILLERMO
分类号 G01N1/30;G01N33/48;G01N33/50;G01N33/574 主分类号 G01N1/30
代理机构 代理人
主权项
地址
您可能感兴趣的专利